Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1371studies shown
Showing 76-100 of 1,371
RecruitingNCT06906939

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

This study is looking at whether a digital support tool can help people with Knee Osteoarthritis or Depression. Participants take part in a digital support tool and complete follow-up assessments.

DepressionOtherFrom 50 Years to 95 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Depression
CompletedNCT05841030

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

This observational study is following people with major depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Brazil, Canada, France, Germany, Italy, South Korea, Spain, Sweden, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Active Not RecruitingNCT03642964

A Study in Patients With Major Depressive Disorder

This study is comparing CTC-501 with placebo for people with depression. Participants receive CTC-501 or placebo and complete study visits and assessments.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Chase Therapeutics Corporation
Condition
Depression
TerminatedNCT05518149

A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)

This study is looking at whether Aticaprant can help people with major depression. Participants take part in Aticaprant and complete follow-up assessments.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
RecruitingNCT07412756

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

This study is comparing Brenipatide with placebo for people with major depression. Participants receive Brenipatide or placebo and complete study visits and assessments.

DepressionOtherFrom 18 Years to 75 Years
Countries
Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, United States, South Korea, Spain, Taiwan, United Kingdom
Sponsor
Eli Lilly and Company
Condition
Depression
RecruitingNCT06793397

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

This study is testing whether CYB003, compared with placebo, is safe and helpful as an add-on treatment for people with depression. Participants receive CYB003 or placebo and complete study visits and assessments.

DepressionOtherFrom 18 Years to 85 Years
Countries
Australia, Czech Republic, Germany, Greece, Ireland, Poland, United Kingdom, United States
Sponsor
Cybin IRL Limited
Condition
Depression
RecruitingNCT07186309

A Study of a Test for Postpartum Depression at Home

This observational study is following people with Postpartum Depression or Pregnancy to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionDeviceOver 18 Years
Countries
United States
Sponsor
University of Virginia
Condition
Depression
RecruitingNCT06524830

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

This observational study is following people with Treatment Resistant Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionOtherFrom 18 Years to 65 Years
Countries
Australia, Canada, United Kingdom, United States
Sponsor
atai Therapeutics, Inc.
Condition
Depression
RecruitingNCT07258485

A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)

This observational study is following people with major depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionOtherFrom 18 Years to 74 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
RecruitingNCT07065240

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

This study is looking at whether SPT-300 can help people with depression or depression With Anxious Distress. Participants take part in SPT-300 and complete follow-up assessments.

DepressionOtherFrom 18 Years to 65 Years
Countries
Bulgaria, Czech Republic, Germany, Poland, Slovakia, United States
Sponsor
Seaport Therapeutics
Condition
Depression
RecruitingNCT07196501

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

This study is looking at care and outcomes for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

DepressionOtherOver 18 Years
Countries
Australia, Bulgaria, Canada, Estonia, Italy, Poland, Serbia, South Korea, Spain, Taiwan, United States
Sponsor
Neurocrine Biosciences
Condition
Depression